PRESS RELEASE
1 September 2026

Patrick Keane And Jonathan Spadt Named In IAM Strategy 300: World’s Leading IP Strategists

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
atrick Keane, shareholder in the firm’s Intellectual Property section, and Jonathan Spadt, shareholder and co-chair of the Intellectual Property section...
United States

Patrick Keane, shareholder in the firm's Intellectual Property section, and Jonathan Spadt, shareholder and co-chair of the Intellectual Property section, are recognized among the IAM Strategy 300: World's Leading IP Strategists.

According to IAM, the Strategy 300 showcases the top experts in the IP world. The list represents the breadth of today's IP strategy landscape. It is the only resource of its kind, acknowledging leaders from across in-house, private practice and service provider roles. They include senior figures at major corporations, specialist advisers and service providers, as well as experts from universities and research institutions around the world. A slot in the 300 is the mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature.

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More